S6045 | Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry | Smith & Moses
S6045Senate
Official Title
Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry
2021-2022 SessionPete HarckhamAffects: Public Health Law
Status
In Senate Committee
Health
Impact Rating
Unable to calculate
Passage Likelihood
Unable to calculate
Bill Progress
✓
Introduced
👥
In Committee
✅
Committee Passed
📋
Floor Calendar
🏛️
Passed Chamber
🔄
Other Chamber
✓
Introduced
👥
In Committee
✅
Committee Passed
📋
Floor Calendar
🏛️
Passed Chamber
🔄
Other Chamber
What's Happening
Why It Matters
Waiting for summary...
Stay Updated
Get daily summaries of new legislation delivered to your inbox.
We'll send occasional updates about new bills and features. Unsubscribe anytime.